Susquehanna International Group’s Nemaura Medical, Inc. Common Stock NMRD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-20,230
Closed -$6.53K 13589
2023
Q3
$6.53K Buy
+20,230
New +$14K ﹤0.01% 11756
2023
Q1
Sell
-21,636
Closed -$36.8K 13835
2022
Q4
$36.8K Sell
21,636
-5,635
-21% -$12.4K ﹤0.01% 11551
2022
Q3
$57K Sell
27,271
-16,380
-38% -$32.7K ﹤0.01% 12118
2022
Q2
$113K Sell
43,651
-18,835
-30% -$60.3K ﹤0.01% 11360
2022
Q1
$273K Buy
62,486
+5,186
+9% +$21.7K ﹤0.01% 10498
2021
Q4
$261K Buy
57,300
+34,805
+155% +$187K ﹤0.01% 10822
2021
Q3
$135K Buy
+22,495
New +$162K ﹤0.01% 11870
2021
Q2
Sell
-30,934
Closed -$295K 13452
2021
Q1
$236K Buy
+30,934
New +$205K ﹤0.01% 11104
2018
Q2
Sell
-1,240
Closed -$56K 10636
2018
Q1
$56K Buy
+1,240
New +$65.8K ﹤0.01% 8922

Other funds holding NMRD

Susquehanna International Group's NMRD Position: Q4 2023 in Review

Susquehanna International Group sold out of Nemaura Medical, Inc. Common Stock (NMRD) in Q4 2023, closing a stake of 20,230 shares — an estimated $6.53K sold.

Susquehanna International Group first reported a position in NMRD in Q1 2018 and held it in 9 quarters. The position peaked at $273K in Q1 2022. 21 funds tracked by Wall St. Rank hold NMRD as of Q4 2023.

  • Susquehanna International Group reported no remaining Nemaura Medical, Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
  • Susquehanna International Group sold 20,230 Nemaura Medical, Inc. Common Stock shares in Q4 2023, an estimated $6.53K.
  • Susquehanna International Group first reported a position in Nemaura Medical, Inc. Common Stock in Q1 2018 and held it in 9 quarters.
  • Susquehanna International Group's Nemaura Medical, Inc. Common Stock position peaked at $273K in Q1 2022.
  • 21 funds tracked by Wall St. Rank held Nemaura Medical, Inc. Common Stock as of Q4 2023.

Based on Susquehanna International Group's 13F filing for Q4 2023, filed 14 Feb 2024.